Episode 364 showcases our hosts Dr Jake Sloane & David Segal.
In our 'What's trending in Aesthetics?' episodes we discuss popular topics doing the rounds on social media, issues being debated in injector forums or items showcased on the news. We'll cover controversies, big stories and themes that have got injectors and our industry talking.
In Chapter 19 we delve into five topics:
The growing influence of private equity in aesthetics and what Obagi Medical's sale could mean for clinics
Allergan's "Undetectable Era" and the evolving definition of natural-looking results
Patient education and clinical photography
Counterfeit toxin concerns and patient safety following an FDA warning letter
AI-accelerated longevity research and what emerging technology could mean for the future of aesthetics
00:00 Introduction 01:28 IA Community Explained 04:08 Obagi Sold To PE 05:42 Private Equity Pros And Cons 14:44 Clinic Stocking Concerns 16:40 Allergan And The Natural Look 19:27 What Natural Really Means 21:46 Patient Education Basics 22:15 Biostimulators Vs Fillers 23:13 Consultation Photos That Sell 24:17 FDA Toxin Warning Letter 26:33 Counterfeit Product Risks 28:28 How Patients Verify Safety 30:05 David Sinclair And Longevity 32:29 AI Accelerating Research 38:30 What It Means For Aesthetics 41:09 Would You Take It? 41:41 Live Event And Wrap Up
Podden och tillhörande omslagsbild på den här sidan tillhör
Inside Aesthetics. Innehållet i podden är skapat av Inside Aesthetics och inte av,
eller tillsammans med, Poddtoppen.
